Serum 25(OH)D Level on Hospital Admission Associated With COVID-19 Stage and Mortality - PubMed (original) (raw)
Observational Study
Serum 25(OH)D Level on Hospital Admission Associated With COVID-19 Stage and Mortality
Dieter De Smet et al. Am J Clin Pathol. 2021.
Abstract
Objectives: Vitamin D deficiency was previously correlated with incidence and severity of coronavirus disease 2019 (COVID-19). We investigated the association between serum 25-hydroxyvitamin D (25(OH)D) level on admission and radiologic stage and outcome of COVID-19 pneumonia.
Methods: A retrospective observational trial was done on 186 severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-infected individuals hospitalized from March 1, 2020, to April 7, 2020, with combined chest computed tomography (CT) and 25(OH)D measurement on admission. Multivariate regression analysis was performed to study if vitamin D deficiency (25(OH)D <20 ng/mL) correlates with survival independently of confounding comorbidities.
Results: Of the patients with COVID-19, 59% were vitamin D deficient on admission: 47% of females and 67% of males. In particular, male patients with COVID-19 showed progressively lower 25(OH)D with advancing radiologic stage, with deficiency rates increasing from 55% in stage 1 to 74% in stage 3. Vitamin D deficiency on admission was not confounded by age, ethnicity, chronic lung disease, coronary artery disease/hypertension, or diabetes and was associated with mortality (odds ratio [OR], 3.87; 95% confidence interval [CI], 1.30-11.55), independent of age (OR, 1.09; 95% CI, 1.03-1.14), chronic lung disease (OR, 3.61; 95% CI, 1.18-11.09), and extent of lung damage expressed by chest CT severity score (OR, 1.12; 95% CI, 1.01-1.25).
Conclusions: Low 25(OH)D levels on admission are associated with COVID-19 disease stage and mortality.
Keywords: 25(OH)D; COVID-19 disease; Coronavirus; Laboratory analysis; SARS-CoV-2; Viral pneumonia; Vitamin D deficiency.
© American Society for Clinical Pathology, 2020. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.
Figures
Image 1
Levels of 25-hydroxyvitamin D (25(OH)D) in male and female patients with coronavirus disease 2019 (COVID-19) grouped by radiologic COVID-19 disease stage. A-C, Representative images of radiologic stages of COVID-19 lung disease with predominantly ground-glass opacities in early stage 1 (A), crazy paving patterns in progressive stage 2 (B), and consolidation in peak stage 3 (C).
Figure 1
Box-and-whisker plots of 25-hydroxyvitamin D (25(OH)D) in male patients with coronavirus disease 2019 (COVID-19) (A) and female patients with COVID-19 (B) grouped according to radiologic stage (stage 1, early stage ground-glass opacities; stage 2, progressive stage, crazy paving pattern; stage 3, peak stage, consolidation). Background color in boxplots indicates normal vitamin D status (green, 25(OH)D >30 ng/mL), vitamin D deficiency (pale red, 25(OH)D <20 ng/mL), severe vitamin D deficiency (darker red, 25(OH)D <12 ng/mL), and a gray zone (20 ng/mL ≤ 25(OH)D ≤ 30 ng/mL). P values indicate statistical differences between groups calculated by the Mann-Whitney test. Exact P values are listed in the supplementary information.
Comment in
- Importance of the Lipid-Bound Character of Vitamin D Binding Protein in the Evaluation of Vitamin D Status in COVID-19 Patients.
Speeckaert MM, Delanghe JR. Speeckaert MM, et al. Am J Clin Pathol. 2021 Apr 26;155(5):766-767. doi: 10.1093/ajcp/aqaa271. Am J Clin Pathol. 2021. PMID: 33399186 Free PMC article. No abstract available.
Similar articles
- The relationship between 25(OH) vitamin D levels and COVID-19 onset and disease course in Spanish patients.
Diaz-Curiel M, Cabello A, Arboiro-Pinel R, Mansur JL, Heili-Frades S, Mahillo-Fernandez I, Herrero-González A, Andrade-Poveda M. Diaz-Curiel M, et al. J Steroid Biochem Mol Biol. 2021 Sep;212:105928. doi: 10.1016/j.jsbmb.2021.105928. Epub 2021 Jun 6. J Steroid Biochem Mol Biol. 2021. PMID: 34091026 Free PMC article. - Pre-infection 25-hydroxyvitamin D3 levels and association with severity of COVID-19 illness.
Dror AA, Morozov N, Daoud A, Namir Y, Yakir O, Shachar Y, Lifshitz M, Segal E, Fisher L, Mizrachi M, Eisenbach N, Rayan D, Gruber M, Bashkin A, Kaykov E, Barhoum M, Edelstein M, Sela E. Dror AA, et al. PLoS One. 2022 Feb 3;17(2):e0263069. doi: 10.1371/journal.pone.0263069. eCollection 2022. PLoS One. 2022. PMID: 35113901 Free PMC article. - Influence of vitamin D status on hospital length of stay and prognosis in hospitalized patients with moderate to severe COVID-19: a multicenter prospective cohort study.
Reis BZ, Fernandes AL, Sales LP, Santos MD, Dos Santos CC, Pinto AJ, Goessler KF, Franco AS, Duran CSC, Silva CBR, Macêdo MB, Dalmolin HHH, Baggio J, Balbi GGM, Antonangelo L, Caparbo VF, Gualano B, Murai IH, Pereira RMR. Reis BZ, et al. Am J Clin Nutr. 2021 Aug 2;114(2):598-604. doi: 10.1093/ajcn/nqab151. Am J Clin Nutr. 2021. PMID: 34020451 Free PMC article. - The relationship between the severity and mortality of SARS-CoV-2 infection and 25-hydroxyvitamin D concentration - a metaanalysis.
Oscanoa TJ, Amado J, Vidal X, Laird E, Ghashut RA, Romero-Ortuno R. Oscanoa TJ, et al. Adv Respir Med. 2021;89(2):145-157. doi: 10.5603/ARM.a2021.0037. Adv Respir Med. 2021. PMID: 33966262 Review. - Perspective: Vitamin D deficiency and COVID-19 severity - plausibly linked by latitude, ethnicity, impacts on cytokines, ACE2 and thrombosis.
Rhodes JM, Subramanian S, Laird E, Griffin G, Kenny RA. Rhodes JM, et al. J Intern Med. 2021 Jan;289(1):97-115. doi: 10.1111/joim.13149. Epub 2020 Jul 22. J Intern Med. 2021. PMID: 32613681 Free PMC article. Review.
Cited by
- Assessment of Supplementation with Different Biomolecules in the Prevention and Treatment of COVID-19.
González-Acedo A, Manzano-Moreno FJ, García-Recio E, Ruiz C, Luna-Bertos E, Costela-Ruiz VJ. González-Acedo A, et al. Nutrients. 2024 Sep 11;16(18):3070. doi: 10.3390/nu16183070. Nutrients. 2024. PMID: 39339670 Free PMC article. Review. - Serum 25-hydroxyvitamin D levels and health outcomes of hospitalization owing to COVID-19: a retrospective cross-sectional study.
Metonidze I, Bostoganashvili N, Goderidze T, Tananashvili D. Metonidze I, et al. J Int Med Res. 2024 Aug;52(8):3000605241271770. doi: 10.1177/03000605241271770. J Int Med Res. 2024. PMID: 39188127 Free PMC article. - The role of micronutrients in the management of COIVD-19 and optimizing vaccine efficacy.
Altooq N, Humood A, Alajaimi A, Alenezi AF, Janahi M, AlHaj O, Jahrami H. Altooq N, et al. Hum Nutr Metab. 2022 Mar;27:200141. doi: 10.1016/j.hnm.2022.200141. Epub 2022 Jan 25. Hum Nutr Metab. 2022. PMID: 38620928 Free PMC article. Review. - Vitamin D Supplementation in Neonatal and Infant MIS-C Following COVID-19 Infection.
Rizzi M, Avellis V, Messina A, Germano C, Tavella E, Dodaro V, Vitale R, Revelli A, Zola P, Picone S, Paolillo PM, Mondì V, Masturzo B, Manzoni P, Sainaghi PP. Rizzi M, et al. Int J Mol Sci. 2024 Mar 27;25(7):3712. doi: 10.3390/ijms25073712. Int J Mol Sci. 2024. PMID: 38612523 Free PMC article. Review. - Efficiency of the Vitamin D Status Diagnosticator amongst Geriatric Patients with COVID-19.
Charonnat C, Sanchez-Rodriguez D, Karras SN, Gezen-Ak D, Dursun E, Annweiler C. Charonnat C, et al. Nutrients. 2024 Mar 15;16(6):856. doi: 10.3390/nu16060856. Nutrients. 2024. PMID: 38542767 Free PMC article.
References
- Chirumbolo S, Bjørklund G, Sboarina A, et al. The role of vitamin D in the immune system as a pro-survival molecule. Clin Ther. 2017;39:894-916. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous